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Background: Progesterone (P4) may modulate oviductal functions to promote early embryo development in cattle.
In addition to its nuclear receptor (PR), P4 may mediate its actions through P4 receptor membrane component 1
(PGRMC1) and its relative, PGRMC2. Two successive experiments were undertaken to characterise the expression of
PR, PGRMC1 and PGRMC2 in the bovine oviduct during the post-ovulation period, and to relate their expression to
the presence of an embryo, the proximity of the CL and to the region of the oviduct.
Methods: In the first experiment (Exp. I), whole oviduct sections were collected from Holstein cows at Day 1.5, Day
4 and Day 5 post-ovulation (n = 2 cows per stage). The expression of PR, PGRMC1 and PGRMC2 was studied in the
ampulla and isthmus by RT-PCR, western-blot and immunohistochemistry. In Exp. II, oviduct epithelial cells were
collected from cyclic and pregnant Charolais cows (n = 4 cows per status) at Day 3.5 post-ovulation and mRNA
expression of PR, PGRMC1 and PGRMC2 was examined in the ampulla and isthmus by real-time quantitative PCR.
Results: In Exp. I, PR, PGRMC1 and PGRMC2 were expressed in all oviduct samples. PGRMC1 was mainly localised in
the luminal epithelium whereas PR and PGRMC2 were localised in the epithelium as well as in the muscle and
stroma layers of the oviduct. The expression was primarily nuclear for PR, primarily cytoplasmic for PGRMC1 and
both nuclear and cytoplasmic for PGRMC2. In Exp. II, mRNA levels for PR, PGRMC1 and PGRMC2 were not affected
by either the pregnancy status or the side relative to the CL. However, the expression of PR and PGRMC2 varied
significantly with the region of the oviduct: PR was more highly expressed in the isthmus whereas PGRMC2 was
more highly expressed in the ampulla.
Conclusions: This is the first evidence of PGRMC2 expression in the bovine oviduct. Our findings suggest that P4
regulates the functions of the bovine oviduct in a region-specific manner and through both classical and non
classical pathways during the post-ovulation period.
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Progesterone (P4) plays a key role in the establishment
and maintenance of pregnancy in cattle [1]. Several
studies have demonstrated a positive association be-
tween milk or plasma P4 concentration in the immedi-
ate post-insemination period and bovine embryo
survival and/or development [2-6]. This positive effect
of P4 on embryo survival in inseminated cows was by-
passed by transfer into the uterus of lactating Holstein
cows of fresh morulas or blastocysts [2], suggesting that
P4 may improve early embryo development via changes
in the oviductal environment during the first days of
pregnancy. Indeed, bovine embryos develop to the mor-
ula stage within the oviduct in the first 5 days of preg-
nancy, before entering the uterus [1]. The proximal part
of the oviduct, referred to as the ampulla, is particularly
implicated in the transport of the oocyte-cumulus com-
plex and fertilisation, whereas the distal part, named the
isthmus, is responsible for sperm storage and embryo
transport toward the uterus [7-9]. The oviduct epithe-
lium provides nutrients (e.g. energetic substrates, ions,
amino acids) and local growth factors [10,11], that can
be modified quantitatively [12] and qualitatively [13] by
circulating P4 secreted by the corpus luteum (CL).
Moreover, P4 could influence embryo development
through the regulation of its transport to the uterus
[14]. In cattle, P4 has been shown to reduce oviduct mo-
tility in vivo [15] and to reduce ciliary motility in tubal
explants ex vivo through rapid non genomic actions
[16]. However, the mechanisms by which P4 modulates
the tubal micro-environment in cattle are still poorly
understood.
P4 may act in the oviduct through at least two types of
receptors: the conventional nuclear receptor PR, that
exists in two isoforms PRA and PRB (arising from a sin-
gle gene) which are both expressed in the bovine oviduct
[17,18], and two potential P4 receptors, referred to as
progesterone receptor membrane component (PGRMC)
1 and the closely related PGRMC2, encoded by two dif-
ferent genes [19]. While minimal information is available
concerning PGRMC2, PGRMC1 is a vertebrate 26–28
kDa protein that contains a single membrane-spanning
domain and belongs to the membrane-associated P4 re-
ceptor (MAPR) family [20]. Recent studies suggest that
PGRMC1 mediates several P4 actions in reproductive
organs, such as anti-apoptotic action in rat granulosa
cells [21], sperm acrosome reaction in porcine and
human [22], oocyte maturation in bovine [23,24] and
myometrium relaxation during pregnancy in human
[25]. Furthermore, PGRMC1 has recently been immuno-
localised in the bovine genital tract, including the ovi-
duct, during the oestrous cycle [26].
In order to explore the expression of nuclear and
membrane P4 receptors in the bovine oviduct during thepost-ovulation period, two experiments were carried out.
The first experiment (Exp. I) was undertaken to detect
mRNA and localise protein expression of PR, PGRMC1
and PGRMC2 in the bovine oviduct during the first 5
days post-ovulation. The second experiment (Exp. II)
was designed to compare the expression of these three
receptors in oviduct epithelial cells at Day 3.5 post-
ovulation in relation to the pregnancy status, to the side
relative to the CL and to the region of the oviduct.
Methods
Treatment of animals and oviduct collection
All procedures described within were approved by the
Regional Ethical Committee of Paris-Sud and performed
in accordance with the International Guiding Principles
for Biomedical Research Involving Animals.
In Exp. I, six non lactating Holstein cows (age: 7.0± 1.4
years) were synchronised using a subcutaneous implant of
P4 (Crestar SOW, Intervet-Schering-Plough, Angers, France)
left for 10 days, with 500 μg of cloprostenol (EstrumateW,
Intervet-Schering-Plough) IM-injected 2 days before im-
plant removal and 400 IU equine Chorionic Gonadotropin
(CHRONO-GESTW PMSG, Intervet-Schering-Plough) IM-
injected on the day of implant removal. Day 0 was consid-
ered as the day of presumed ovulation, i.e. 48 h after im-
plant removal. Cows were killed either at Day 1.5, Day 4 or
Day 5 post-ovulation (n=2 for each stage) in a local INRA
slaughterhouse for tissue collection.
In Exp. II, 20 multiparous non lactating Charolais
cows (age: 7.1 ± 0.3 years) were synchronised for oestrus
using a subcutaneous implant of P4 (Crestar SOW)
inserted for 11 days, with 10.5 μg busereline acetate
(ReceptalW, Intervet-Schering-Plough) IM-injected on
the day of implant insertion, 15 mg luprostiol (Prosol-
vinW, Virbac, Carros, France) IM-injected 2 days before
implant removal and 400 IU equine Chorionic Gonado-
tropin (CHRONO-GESTW PMSG) IM-injected on the
day of implant removal. Day 0 was considered as the day
of presumed ovulation, i.e. 48 h after implant removal.
In order to get pregnant oviducts, 12 cows out of 20
were artificially inseminated twice at Day 0 and Day 0.5.
All cows were killed at Day 3.5 post-ovulation for tissue
collection in a local INRA slaughterhouse. In Exp. I and
II, ovaries and genital tract were recovered from cows
within 20 min of death. Cows that did not ovulate or
that did ovulate twice (two corpora lutea) were dis-
carded. Furthermore, the appearance of the CL varied
with the post-ovulation stage: a small corpus hemorrha-
gicum was observed at Day 1.5 post-ovulation, a very
early corpus luteum, occasionally filled with blood, was
observed at Days 3.5-4 post-ovulation, and a large cor-
pus luteum was observed at Day 5 post-ovulation, as
previously described [27]. Oviducts ipsilateral and
contralateral to the CL were separated from the uterus
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tissue then flushed with 2 ml of Phosphate Buffer Saline
(PBS, Sigma, Saint-Quentin Fallavier, France). In Exp. II,
the flushing from the oviduct ipsilateral to the CL was
examined under the microscope for the presence of an
oocyte or an embryo. Non inseminated and inseminated
cows in which no oocyte and no embryo, respectively,
could be recovered, were excluded. Eventually, four cyc-
lic cows (for which one oocyte was found in the ovi-
ductal flushing) and four pregnant cows (for which one
embryo at the 8- to 16-cell stage was found in the ovi-
ductal flushing) were analyzed in Exp. II.Preparation of oviduct samples
In Exp. I, ampulla and isthmus were separated then cut
into 1-cm long sections and whole tissues were either
snap frozen in liquid nitrogen or embedded in OCT
(Embedding Matrix, Cellpath, Newton, UK), then frozen
in liquid nitrogen vapours and stored at – 80°C pending
analysis.
In Exp. II, the ampulla and isthmus were opened lon-
gitudinally and oviduct epithelial cells were recovered by
scraping the mucosal layer with a sterile scalpel. Cells
from both regions were immediately transferred into a
sterile cryotube and snap frozen in liquid nitrogen then
stored at – 80°C pending analysis.Preparation of cDNAs
In Exp. I, total RNA was extracted from whole oviduct
sections in TRIzol reagent (Invitrogen, Cergy-Pontoise,
France) using a homogeniser (PolytronW PT-MR 2100,
Kinematica AG, Littau, Switzerland), then treated with
recombinant DNase I (Roche Applied Science,
Mannheim, Germany) as described in the manufacturer’sTable 1 Primer sets used in conventional and real-time PCR
Gene name (abbreviation) GenBank access
Progesterone receptor (PR) AY656812
Progesterone receptor membrane component 1 (PGRMC1) BC1184441
Progesterone receptor membrane component 2 (PGRMC2) NM_001099060
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) NM_001034034
Solute carrier family 30 (zinc transporter),
member 6 (SLC30A6)
NM_001075766
Beta actin (ACTB) NM_173979instructions, and stored at −80°C until use in reverse
transcription (RT).
In Exp. II, total RNA was extracted from oviduct cells
using the RNeasy Mini kit (Qiagen, Courtaboeuf,
France) then treated with RNase Inhibitor (40 U/μl; Invi-
trogen) and recombinant DNase I (Roche Applied Sci-
ence). RNA samples were then migrated on an ethidium
bromide-treated 1% agarose gel to assess their integrity
(by observation of 18S and 28S rRNA intensities after
UV light exposure). Six RNA samples (out of 32) were
suboptimal and discarded.
In both studies, RNA samples were quantified by spec-
trophotometry and 1 μg was reverse transcribed using
oligo(dT) primers (Invitrogen) and the Superscript II re-
verse transcriptase (Invitrogen) in a 20-μl reaction mix-
ture according to manufacturer’s instructions. The
reverse-transcribed cDNA was diluted 5 times (100 μl
final volume) and stored at – 20°C until used as tem-
plate in conventional or real-time quantitative PCR
mixture.Amplification of cDNA by conventional and quantitative
real-time PCR (qPCR)
Same primer sets were used in both conventional and
qPCR. Primer sets were developed using known bovine
sequences and designed using the Primer 3 web interface
[28] for target genes and using Primer Express software
(v3.0, Applied Biosystems, Life Technologies, Carlsbad,
CA, USA) for two reference genes, GAPDH and
SLC30A6 (see Table 1 for details). Primers for PR were
designed to detect both PRA and PRB isoforms. The
specificity of each conventional and quantitative PCR
products was verified in the Basic Local Alignment
Search Tool [29] and by DNA sequencing (Beckman
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(Eppendorf, Hamburg, Germany). Reactions were per-
formed in a 25-μl mixture containing 0.5 IU of Taq poly-
merase and 5× buffer (QBiogene, Illkirch, France),
0.5 μM of each primer, 10 mM dNTPs, and 1 μl of
diluted cDNA. A negative control using water instead of
cDNA was added to each PCR reaction. The amplifica-
tion of ACTB cDNA was used as internal control (pri-
mer sequences in Table 1). Reaction times were: 1 min
at 94°C then 35 cycles of 30 sec at 94°C, 30 sec at 60°C
and 30 sec at 72°C, then 15 min at 72°C. The amplified
products were resolved by electrophoresis on an eth-
idium bromide-treated 2% agarose gel. The quantifica-
tion of mRNAs was examined in Exp. II by qPCR on a
LightCyclerW 480 apparatus (Roche, Mannheim,
Germany). For each gene, a 10-fold dilution series of the
purified PCR product (Wizard PCR Preps DNA Purifica-
tion System, Promega, Madison WI, USA) was amplified
simultaneously with the samples to establish a standard
curve. Reactions were performed in a 20-μl reaction
mixture containing either 5 μl of diluted cDNA or
diluted standard, 10 μl of LightCycler 480 SYBR Green I
Master mix (Roche), 0.3 μM of forward and reverse pri-
mers and PCR-grade water up to the final volume. As
negative control, water instead of cDNA was used. Cyc-
ling conditions were: denaturation at 95°C for 10 min
followed by 45 cycles of amplification (95°C for 10 sec,
60°C for 10 sec and 72°C for 10 sec) with a single acqui-
sition of fluorescence at the end of the extension step.
After amplification, the samples were heated at 0.1°C/sec
from 60 to 97°C with continuous reading of fluorescence
to obtain a melting curve. The specificity of qPCR prod-
uct was verified using the melting curve analysis pro-
gram of the Lightcycler software (LightCyclerW 480
Software release, version 1.5.0.33, Roche). All qPCR pro-
ducts displayed a single peak in the melting curve ana-
lysis (data not shown). The concentration of each gene
was calculated in duplicate by reference to the respective
standard curve using the maximum second-derivative
analysis of the Lightcycler software (Roche). Finally, the
relative level of gene expression was expressed as the
ratio of target gene mean value to the geometric mean
value of the two reference genes, GAPDH and SLC30A6.
Western blot analysis
In order to test the specificity of antibodies raised
against P4 receptors, three oviduct sections from Exp. I
were used for protein extraction and western-blot ana-
lysis. Tissues were homogenized in lysis buffer (Ripa buf-
fer, Pierce, Rockford, USA) containing proteinase and
phosphatase inhibitors for protein extraction. Protein
samples (60 μg) were separated on a SDS-PAGE gel
(Biorad, Marnes-la-Coquette, France) containing 10%
acrylamide and 5% β-mercaptoethanol then transferredonto a 0.2-μm nitrocellulose membrane (Schleicher &
Schuell, Dassel, Germany) overnight at 4°C. Membranes
were blocked with 5% dried milk in Tris Buffer Saline
(TBS: Tris–HCl buffer 10 mM pH 8, NaCl 150 mM) for
1 h then incubated with one of the following primary
antibodies: 1) a monoclonal mouse anti-PR antibody
(MA1-410 raised against a peptide corresponding to
amino acids 553–547 of the human PR; Affinity BioRea-
gents, Golden, USA) and diluted at 1:200; 2) a polyclonal
rabbit anti-PGRMC1 antibody (raised against a peptide
corresponding to amino acids 1–14 of the native porcine
PGRMC1 [30]; gift from Prof. M. Wehling, University
Medicine Mannheim, University of Heidelberg,
Germany) diluted at 1:500; 3) a monoclonal mouse anti-
PGRMC2 antibody (clone 3C11 raised against a peptide
corresponding to amino acids 124–224 of the human
PGRMC2; Sigma-Aldrich, Saint Louis, USA) diluted at
1:200. Loading controls were carried out using either an
anti-α-tubulin (mouse monoclonal antibody, clone
DM1A, Sigma) or an anti-β-actin (mouse monoclonal
antibody, clone AC-74, Sigma) antibody. Membranes
were incubated in 2% dried milk in TBS containing
0.05% of Tween-20 (TBS-Tween) overnight at 4°C. After
washing in TBS-Tween, the membranes were incubated
with either an anti-mouse (for PR and PGRMC2) or an
anti-rabbit (for PGRMC1) horseradish peroxidase-
conjugated IgG secondary antibody (Sigma) at dilutions
of 1:5000 and 1:30.000, respectively, in 2% dried milk in
TBS-Tween for 1 h at room temperature. After washing
in TBS-Tween, the membrane was incubated with
enhanced chemiluminescence reagent detection solution
(Super Signal West Pico, Pierce) for 5 min in the dark.
Finally, a film (Hyperfilm ECL, Amersham Biosciences,
Orsay, France) was exposed to the membrane to
visualize protein expression.
Immunohistochemistry
Frozen oviduct samples from Exp. I were serially sec-
tioned (7 μm) with a cryostat. Sections were mounted
on Superfrost Plus slides (Menzel-Gläser, Braunshweig,
Germany), fixed for 5 min in acetone at – 20°C then
stored at – 80°C until use. Non-specific protein binding
was inhibited by incubation with normal porcine serum
(1:10 dilution in PBS; Interchim, Montluçon, France) for
30 min at room temperature. Sections were incubated
with either the anti-PR antibody (1:1000 dilution in
PBS), the anti-PGRMC1 antibody (1:1000 dilution in
PBS) or the anti-PGRMC2 antibody (1:200 in PBS). Sec-
tions were incubated overnight at 4°C in a moist cham-
ber. After washing in PBS, sections were incubated with
either anti-mouse (for PR and PGRMC2) or anti-rabbit
(for PGRMC1) biotinylated secondary antibodies (LSAB
kit, Dako, Trappes, France) at room temperature for 30
min. Sections were then treated with 3% H2O2 for 5 min
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ase complex (LSAB kit) at room temperature for 15 min.
The signal was detected using a solution of 3-amino-9-
ethylcarbazole (AEC; LSAB kit) for 10 min. Sections
were counterstained with hematoxylin and mounted in
Immu-Mount mounting solution (Thermon Electron,
Courtaboeuf, France) for light microscopy. For control
sections, the primary antibody was replaced at the same
dilution by mouse IgG for PR, rabbit serum for
PGRMC1 or mouse IgG1 for PGRMC2.
Statistical analysis
Data are presented as means ± SEM. For statistical ana-
lysis of qRT-PCR data, the GLM procedure of SAS soft-
ware (SAS Institute Inc., Cary, NC, USA) was used. A
three-way ANOVA was used to study the effect of the
cow status (cyclic versus pregnant), the oviduct side rela-
tive to that of the CL (ipsilateral versus contralateral)
and the oviduct section (ampulla versus isthmus) on
mRNA levels, followed, when necessary, by a multiple
t-test analysis. To account for potential correlations be-
tween observations made on the same cow, the factors
“oviduct side” and “oviduct section” were considered
as repeated measures. A p value < 0.05 was considered
significant.
Results
Experiment I: expression and localisation of PR, PGRMC1
and PGRMC2 in whole oviduct sections between Day 1.5
and Day 5 post-ovulation
Conventional RT-PCR evidenced the expression of PR,
PGRMC1 and PGRMC2 mRNAs in both ipsilateral and





Figure 1 Expression of PR, PGRMC1 and PGRMC2 mRNAs in the bovin
PGRMC2 (C) detected by conventional RT-PCR in bovine whole oviduct sec
repeated twice and one representative assay is shown. Arrows indicate the
isthmus; C-A: contralateral ampulla; C-I: contralateral isthmus.Day 5 post-ovulation (Figure 1) whereas negative controls
using water instead of cDNA showed no signal (data not
shown).
The specificity of antibodies raised against target pro-
teins was examined by western blot analysis. The anti-
PR antibody detected both PR-A (95 kDa) and PR-B
(120 kDa) isoforms in the ampulla and isthmus at each
stage examined (see Figure 2 for one ampulla at Day 5).
Western blotting analysis of the same oviduct sample
detected two bands at 23 kDa and 28 kDa using the
anti-PGRMC1 antibody, and a single band at 26 kDa
using the anti-PGRMC2 antibody (Figure 2).
Immunocytochemistry for PR revealed a specific nu-
clear staining in the luminal epithelium, the stromal cells
and the muscle layer in both the ampulla (Figures 3A, B)
and the isthmus (Figures 3C, D). A weak cytoplasmic
staining was also present in the luminal epithelium in
both oviductal sections (Figure 3A inset, C). Examin-
ation of PGRMC1 localisation revealed an intense cyto-
plasmic staining in the luminal epithelium in both the
ampulla (Figures 4A, B) and the isthmus (Figures 4C, D),
while the muscular and stromal layers were weakly stained
in both parts of the oviduct. Examination of PGRMC2 lo-
calisation revealed a cytoplasmic staining in the luminal
epithelium and a nuclear staining in the stromal and
muscle layers in both the ampulla (Figures 5A, B) and the
isthmus (Figures 5C, D). Higher magnification showed a
discrete nuclear PGRMC2 staining in the epithelial com-
partment (Figure 5A inset). No obvious differences in lo-
calisation patterns of PR, PGRMC1 and PGRMC2 were
observed between ipsi- and contralateral oviducts or










e oviduct. Messenger RNA transcripts for PR (A), PGRMC1 (B) and
tions at Day 1.5, Day 4 and Day 5 post-ovulation. Experiments were













Figure 2 Western blots for PR, PGRMC1 and PGRMC2 in the bovine oviduct. Western blot analysis of PR, PGRMC1 and PGRMC2 in one
bovine whole ampulla section at Day 5 post-ovulation. Molecular weight markers are indicated on the left of each blot and molecular weights of
the bands are indicated on the right. Experiments were repeated three times and one representative blot is shown.
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mRNAs in oviduct epithelial cells at Day 3.5 post-
ovulation
To further characterise the expression of P4 receptors, a
RT-qPCR approach was applied to oviduct epithelial cells
at Day 3.5 post-ovulation in both cyclic and pregnant
cows. Statistical analysis revealed no effect of either the
cow status (cyclic versus pregnant) or the side relative to
the CL (ipsilateral versus contralateral) on any gene ex-
pression. However, when ipsilateral and contralateral ovi-
ducts were grouped, the expression of PR mRNA was
significantly higher (1.8-fold higher, p = 0.004) in the isth-
mus than in the ampulla in cyclic cows (Figure 6A).
In contrast, while PGRMC1 expression did not varyFigure 3 Localisation of PR in the bovine oviduct by immunohistoche
in the ampulla (A, B) and the isthmus (C, D) of bovine oviducts at Day 1.5
epithelium showing a nuclear and cytoplasmic staining in the epithelial ce
incubated with mouse IgG in place of primary antibody. Black arrows indic
luminal epithelium; S: stroma; M: muscle. Original magnification A-C x200 aaccording to the oviduct section (Figure 6B), the amount
of PGRMC2mRNA was significantly higher (2-fold higher,
p = 0.04) in the ampulla than in the isthmus in cyclic cows
(Figure 6C). The effect of the oviduct region on PR and
PGRMC2 gene expression remained significant when cyc-
lic and pregnant oviducts were pooled (p= 0.03 for both
receptors).
Discussion
Our results demonstrate the expression of PR, PGRMC1
and, for the first time, of PGRMC2, in several compart-
ments of the bovine oviduct between Day 1.5 and Day 5
post-ovulation. To our knowledge, this is the first ex-
ploration of PGRMC1 and PGRMC2 gene expression inmistry. Representative images of PR immunohistochemical localisation
(A, C) and Day 5 (B, D) post-AI. A inset: magnification of the luminal
lls and a nuclear staining in the stromal cells. D inset: control section
ate nuclear staining and arrow heads indicate cytoplasmic staining. LE:
nd D x100. Scale bars: 100 μm.
Figure 4 Localisation of PGRMC1 in the bovine oviduct by immunohistochemistry. Representative images of PGRMC1
immunohistochemical localisation in the ampulla (A, B) and the isthmus (C, D) of bovine oviducts at Day 1.5 (A, C) and Day 5 (B, D) post-AI.
C inset: magnification of the luminal epithelium showing a cytoplasmic staining mainly localised in the epithelial cells. D inset: control section
incubated with rabbit serum in place of primary antibody. Arrow heads indicate cytoplasmic staining. LE: luminal epithelium; S: stroma; M: muscle.
Original magnification A-C x200, D x100 and C inset x1000. Scale bars: 100 μm.
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more highly expressed in epithelial cells from the isth-
mus than from the ampulla, whereas PGRMC2 displayed
an opposite pattern of expression. However, neither theFigure 5 Localisation of PGRMC2 in the bovine oviduct by immunohi
immunohistochemical localisation in the ampulla (A, B) and the isthmus (C
A inset: magnification of the luminal epithelium showing a nuclear and cyt
with mouse IgG1 in place of primary antibody. Black arrows indicate nuclea
epithelium; S: stroma; M: muscle. Original magnification A-D x200 and A inside relative to the CL nor the pregnancy status changed
the gene expression of P4 receptors.
Western blot analysis of PR detected both PRA and
PRB subtypes in oviduct samples, as previously reportedstochemistry. Representative images of PGRMC2
, D) of bovine oviducts at Day 1.5 (A, C) and Day 5 (B, D) post-AI.
oplasmic staining of epithelial cells. D inset: control section incubated
r staining and arrow heads indicate cytoplasmic staining. LE: luminal































































































Figure 6 Quantitative expression of PR, PGRMC1 and PGRMC2 mRNAs in the bovine oviduct. Differential mRNA expression of PR (A),
PGRMC1 (B) and PGRMC2 (C) between the ampulla and the isthmus in bovine oviduct epithelial cells at Day 3.5 post-ovulation in either cyclic or
pregnant cows. Data are means ± SEM of 4 cows for each status (ipsilateral and contralateral oviducts were grouped). Concentrations of mRNAs
were measured in duplicate. Means with designations (*) and (**) are significantly different at p < 0.05 and p< 0.01, respectively.
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PRB bind P4, several studies have shown that, depending
on the cell and target genes, PRA and PRB have remark-
ably different transcriptional activities [31]. However, lit-
tle information is available so far with respect to the
respective roles of PRA and PRB in mediating P4 actionin the mammalian oviduct [32,33]. Nevertheless, in the
present study, nuclear P4 receptors were expressed be-
tween Day 1.5 and Day 5 post-ovulation in both the am-
pulla and the isthmus. These results are in keeping with
earlier reports on PR expression in bovine whole-oviduct
sections [17,34] and in isolated oviduct epithelial cells
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minal epithelial cell layer, as well as in the muscle layer
and stromal tissue, in agreement with earlier reports
using the same anti-PR antibody [18] or some others
[17,34,35] in bovine oviduct samples collected during
the first five days of the oestrous cycle. Accordingly, one
of the latter studies reported that the muscle layer was
positively stained only during the early luteal phase (days
1–5) compared with other phases of the oestrous cycle
in the cow [18].
We observed that PR, PGRMC1 and PGRMC2 were
expressed in both the ampulla and isthmus at all stages
examined. To our knowledge, this is the first report of
PGRMC2 expression in the mammalian oviduct. West-
ern blot analysis for PGRMC2 revealed one band at 26
kDa, as previously described in bovine cumulus and lu-
teal cells [23]. In contrast, two signals at 23 kDa and 28
kDa were observed on PGRMC1 western blots. While
the PGRMC1 protein is usually detected as a single sig-
nal between 24 and 28 kDa [21,23,25,26], multiple bands
were previously reported at the same apparent molecular
weights in murine placental tissues [36], which were
assumed to represent PGRMC1 oligomers [20]. Various
protocols of sample fixation/preparation were used in
the latter and present studies and could explain these
discrepancies. These conflicting findings could be also
attributed to the different tissues/cells and subcellular
compartments analysed. Indeed, an antibody from the
same source was reported to detect a single band in
membrane preparations from human and rat granulosa/
luteal cells [21,37] and multiple bands in whole murine
uterine tissues [36].
PGRMC1 has been reported in various subcellular
locations, including plasma membrane [21,38], cytosol
[36] and nucleus [26,36,37]. In this study, PGRMC1 was
mainly localised in the cytosol of luminal epithelial cells,
and to a lesser extent in muscular and stromal cells. This
differs from findings in a previous study [26] that loca-
lised PGRMC1 in the bovine oviduct: the protein was
observed in both the nucleus and cytoplasm of the lu-
minal epithelium, endothelium and muscle layer at
equivalent staining levels. This divergence may be due to
differences in stages of estrous cycle examined, which
were not precisely timed in the latter study [26], as well
as to differences in antibodies and protocols used. The
fact that we had a clear signal in the nucleus for PR and
PGRMC2 demonstrates, however, the efficacy of the
method used. Furthermore, our results are in keeping
with those of Aparicio et al., [23], who localised
PGRMC1 only in the cytoplasm of bovine cumulus cells.
With the antibody used in the present study, the immu-
nostaining for PGRMC1 was intense in the nucleus of
human and rat granulosa/luteal cells [21,37,39]. How-
ever, the subcellular localization of PGRMC1 wasreported to change dramatically after eCG treatment in
the immature rat ovary [21] and depending on the preg-
nancy stage in the mouse uterus [36]. Thus, the expres-
sion of PGRMC1 in various tissues and subcellular
compartments of the bovine oviduct might be regulated
by the hormonal environment and requires further
investigations. The mRNA and/or protein for PGRMC2
have been detected previously in the murine [36] and
macaque [40] endometrium, human choriodecidua [41],
newborn rat ovary [42], and bovine cumulus cells [23].
Various subcellular localisations for the PGRMC2 pro-
tein were previously observed depending on the species
and cell tissue: throughout the cytoplasm in bovine cu-
mulus cells [23], in the cytoplasm of the luminal and
glandular epithelia and in the nuclei of the stromal cells
in the macaque endometrium [40].
Oviducts in the present study were collected from
cows treated for estrous synchronisation. Although not
well documented, compared with natural cycles, syn-
chronisation protocols may have some impact on the
oviduct physiology. Furthermore, oviduct epithelial cells
from pregnant animals in the present study were col-
lected from cows inseminated twice at Day 0 and Day
0.5 post-ovulation. Although the lumen of the oviducts
was rinsed prior to their use for RNA extraction, sperm
cells attached to the luminal epithelium, especially in the
isthmic sperm reservoir [43], may have been picked up
in these extraction processes. Since PR and also
PGRMC1 and PGRMC2 have been identified in porcine
[30] and human [22] sperm, one may question whether
our results include expression data from bovine sperm
cells. Several sets of data seem to exclude this hypoth-
esis. First, the number of spermatozoa counted per
entire bovine oviduct between 17 and 20 h after insem-
ination is around a few tens [44]. Second, nuclei from
spermatozoa that transit in the female genital tract are
transcriptionally inactive [45] and therefore, mRNAs
from spermatozoa have no chance of being co-amplified
during the RT-qPCR performed on oviduct samples.
Thus, it appears reasonable to exclude possible contam-
ination with bull spermatozoa in our expression data.
While the gene expression of PR in target tissues is
classically up-regulated by estradiol and down-regulated
by P4 [31], the factors that regulate the expression of
PGRMC1 and PGRMC2 are largely unknown. Nonethe-
less, P4 has been identified as a good candidate for the
regulation of PGRMC1 gene expression in mouse brain
and placenta [36,38] as well as in the endometrium of
human [19,46,47] and rhesus monkey [48]. Furthermore,
the gene expression of both PGRMC1 and PGRMC2 was
recently demonstrated in the canine oviduct, in which
their mRNA levels varied significantly with the stage of
the estrous cycle [49]. The bovine oviduct ipsilateral to
the CL has been shown to contain higher levels of P4
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teal phase of the estrous cycle [50]. However, in this
study, quantitative RT-PCR applied on oviduct epithelial
cells did not reveal any significant difference in the gene
expression of PR, PGRMC1 or PGRMC2 between ipsilat-
eral and contralateral oviducts. Accordingly, Rottmayer
et al. [51] reported no difference in PR mRNA expres-
sion between epithelial cells collected from bovine ipsi-
lateral and contralateral oviducts. By a transcriptomic
approach, 35 genes were found to be differentially
expressed between epithelial cells from ipsilateral versus
contralateral bovine oviducts collected at Day 3.5 post-
oestrus [52]. However, in accordance with our findings,
genes for P4 receptors were not among the differentially
expressed genes. Furthermore, the localisation pattern of
the three P4 receptors observed in this study did not re-
veal any difference between the two oviducts. In accord-
ance, PGRMC1 was immunolocalised by others in a
similar pattern in both oviducts from cyclic cows [26].
In this study, the effect of the pregnancy status on the
gene expression of nuclear and membrane P4 receptors
was explored for the first time in the bovine oviduct. Al-
though plasma P4 concentrations do not differ between
cyclic and pregnant cows at Day 3.5 post-ovulation [53],
local differences in tubal vascularisation and ciliary beat-
ing in the bovine oviduct epithelium were previously
shown to depend on the presence or absence of an
embryo [8,9]. However, here, the pregnancy status did
not influence the expression of any of the P4 receptors
at Day 3.5 post-ovulation. Similarly, in the bovine endo-
metrium, the level of PR mRNAs was not influenced by
the pregnancy status during the early post-ovulation
period (Days 5–7) [54]. Our results do not exclude dif-
ferential expression of these receptors between cyclic
and pregnant cows in other oviductal tissue layers or at
later stages post-ovulation. Indeed, in the bovine endo-
metrium, PR mRNA concentration was lower in preg-
nant cows than in cyclic cows at Day 13 post-ovulation,
but not earlier [54].
In the present study, the PR gene was more highly
expressed in epithelial cells from the isthmus than from
the ampulla, whereas PGRMC2 displayed an opposite
pattern of expression. Higher amounts of PR mRNAs in
the isthmus compared with the ampulla were previously
reported in the bovine [18,34] and rat [32] oviduct lu-
minal epithelia. However, in the pig oviduct, PR mRNAs
were measured at comparable levels in both oviduct
regions [55]. As the ampulla is mainly implicated in oo-
cyte transport and fertilisation [7], a positive effect of
PGRMC2 in these tubal events might be assumed. Fur-
thermore, a higher expression of PR in the isthmus
might have beneficial effects in the specific functions of
this part of the oviduct, i.e. in the storage of spermato-
zoa before fertilisation and/or in the timed transport ofthe embryo toward the utero-tubal junction [7]. The fac-
tors that could regulate the differential gene expression
of PR and PGRMC2 in the two parts of the bovine ovi-
duct are still unknown. Previous measurement of P4
levels in whole-oviduct sections collected during the first
5 days post-ovulation revealed no difference in P4 con-
centrations between the ampulla and isthmus [50]. Thus,
it seems likely that factors other than local P4 regulate
the region-specific gene expression of PR and PGRMC2
in the oviduct epithelium.
An important question remains the potential roles of
nuclear and membrane P4 receptors in the regulation of
tubal functions. A role for PGRMC1 in the mediation of
the anti-apoptotic effects of P4 has been reported in ovar-
ian granulosa cells [19-21,56]. Furthermore, PGRMC1 has
been recently implicated in the mediation of myometrium
relaxation during pregnancy in human [25]. Of interest, a
proteomic approach showed that PGRMC2 was up-
regulated in the human choriodecidua during term and
preterm labor [41]. A central role of the oviduct during
the post-ovulation period is to allow the transport of the
cumulus-oocyte complex to the site of fertilisation, then of
the early embryo toward the uterus, achieved by synchro-
nised ciliary beating, smooth muscle contraction and flow
of tubal secretions [14]. It might be assumed that both
PGRMC1 and PGRMC2 are involved in tubal contraction
and relaxation. However, as both receptors were expressed
in the luminal epithelium, the mediation of P4 action on
tubal ciliary beating or fluid secretion cannot be excluded.
Further experiments would be required to determine the
potential functions of P4 nuclear and membrane receptors
in the bovine oviduct.Conclusions
The present study confirms the expression of PR and
PGRMC1 and demonstrates for the first time the expres-
sion of PGRMC2 in several compartments of the bovine
oviduct. Furthermore, the expression of PR and PGRMC2
mRNAs in oviduct epithelial cells at Day 3.5 post-
ovulation varied with the oviduct region. These results
suggest that P4 regulates the tubal micro-environment in
the early post-ovulation period in the cow and mediates
its actions through classical as well as non classical
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